Lurasidone hydrochloride and Obstructive airways disorder - a phase IV clinical study of FDA data

Summary:

Obstructive airways disorder is reported as a side effect among people who take Lurasidone hydrochloride (lurasidone hydrochloride), especially for people who are male, 60+ old, also take Avapro, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Obstructive airways disorder when taking Lurasidone hydrochloride. It is created by eHealthMe based on reports of 886 people who have side effects when taking Lurasidone hydrochloride from the FDA, and is updated regularly.

What is Lurasidone hydrochloride?

Lurasidone hydrochloride has active ingredients of lurasidone hydrochloride. eHealthMe is studying from 925 Lurasidone hydrochloride users. Check the latest studies of Lurasidone hydrochloride.

What is Obstructive airways disorder?

Obstructive airways disorder (a progressive disease that makes it hard to breathe) is found to be associated with 904 drugs and 1,225 conditions by eHealthMe. Check the latest studies of Obstructive airways disorder.

On Apr, 20, 2026

886 people reported to have side effects when taking Lurasidone hydrochloride.
Among them, 15 people (1.69%) have Obstructive airways disorder.

Could Lurasidone hydrochloride cause Obstructive airways disorder?

Among these 15 people:

What is the gender of people who have Obstructive airways disorder when taking Lurasidone hydrochloride? *

female: 0.0 %
male: 100 %

What is the age of people who have Obstructive airways disorder when taking Lurasidone hydrochloride? *

What are other drugs people take besides Lurasidone hydrochloride? *

Omeprazole: 15 people, 100.00%
Naproxen: 15 people, 100.00%
Lipitor: 15 people, 100.00%
Latuda: 15 people, 100.00%
Folic Acid: 15 people, 100.00%
Felodipine: 15 people, 100.00%
Enbrel: 15 people, 100.00%
Cytotec: 15 people, 100.00%
Ciprofloxacin Hydrochloride: 15 people, 100.00%
Avapro: 15 people, 100.00%

What are other side effects people have besides Obstructive airways disorder? *

Thrombocytosis: 15 people, 100.00%
Gait Disturbance: 15 people, 100.00%
Joint Pain: 15 people, 100.00%
Joint Effusion (presence of extra fluid in joint covering): 15 people, 100.00%
Insomnia (sleeplessness): 15 people, 100.00%
Inflammation: 15 people, 100.00%
Hypoaesthesia (reduced sense of touch or sensation): 15 people, 100.00%
Haematochezia (passage of stools containing blood): 15 people, 100.00%
Grip Strength Decreased: 15 people, 100.00%
Fatigue (feeling of tiredness): 15 people, 100.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 15 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lurasidone hydrochloride and have Obstructive airways disorder?

- Check whether Obstructive airways disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lurasidone hydrochloride:

Lurasidone hydrochloride (925 reports)

Browse all side effects of Lurasidone hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Obstructive airways disorder:

Obstructive airways disorder (904 drugs)

Browse all the conditions that are associated with Obstructive airways disorder:

Obstructive airways disorder (1,225 conditions)

Related publications that referenced our studies

Reddy, B., Das, S., & Ali, M. , "A Case of Hypersexuality Probably Associated With Lurasidone", Journal of clinical psychopharmacology, 2018 Jan .
Sood S, "Neutropenia with Multiple Antipsychotics Including Dose Dependent Neutropenia with Lurasidone", Clinical Psychopharmacology and Neuroscience, 2017 Jan .
Reddy, B., Das, S., & Ali, M. , "A Case of Hypersexuality Probably Associated With Lurasidone", Journal of clinical psychopharmacology, 2018 Jan .
Sood S, "Neutropenia with Multiple Antipsychotics Including Dose Dependent Neutropenia with Lurasidone", Clinical Psychopharmacology and Neuroscience, 2017 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on lurasidone hydrochloride (the active ingredients of Lurasidone hydrochloride) and Lurasidone hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.